These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15542367)

  • 1. From genome to vaccine--new immunoinformatics tools for vaccine design.
    De Groot AS; Berzofsky JA
    Methods; 2004 Dec; 34(4):425-8. PubMed ID: 15542367
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoinformatics: an integrated scenario.
    Tomar N; De RK
    Immunology; 2010 Oct; 131(2):153-68. PubMed ID: 20722763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution and evolvability of proteins in the laboratory.
    Deem MW
    Proc Natl Acad Sci U S A; 2004 Mar; 101(12):3997-8. PubMed ID: 15024102
    [No Abstract]   [Full Text] [Related]  

  • 4. Harnessing bioinformatics to discover new vaccines.
    Davies MN; Flower DR
    Drug Discov Today; 2007 May; 12(9-10):389-95. PubMed ID: 17467575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomics: discovering new targets for vaccines and therapeutics.
    De Groot AS
    Drug Discov Today; 2006 Mar; 11(5-6):203-9. PubMed ID: 16580597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in next generation immunoinformatics harnessed for universal coronavirus vaccine design.
    Lim CP; Kok BH; Lim HT; Chuah C; Abdul Rahman B; Abdul Majeed AB; Wykes M; Leow CH; Leow CY
    Pathog Glob Health; 2023 Mar; 117(2):134-151. PubMed ID: 35550001
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Reguzova A; Ghosh M; Müller M; Rziha HJ; Amann R
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32531997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T Cells That Trigger Protection against Experimental Visceral Leishmaniasis.
    Brito RCF; Ruiz JC; Cardoso JMO; Ostolin TLVDP; Reis LES; Mathias FAS; Aguiar-Soares RDO; Roatt BM; Corrêa-Oliveira R; Resende DM; Reis AB
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32471081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of the Multi-Epitopic Recombinant Glycoproteins of Newcastle Disease Virus: Implications for the Serodiagnosis Applications.
    Motamedi MJ; Shahsavandi S; Amani J; Kazemi R; Takrim S; Jafari M; Salmanian AH
    Iran J Biotechnol; 2018 Dec; 16(4):e1749. PubMed ID: 31457034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination.
    Muthusamy K; Gopinath K; Nandhini D
    Indian J Med Res; 2016 Oct; 144(4):587-591. PubMed ID: 28256468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates.
    Paul S; Sidney J; Sette A; Peters B
    Curr Protoc Immunol; 2016 Aug; 114():18.19.1-18.19.24. PubMed ID: 27479659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases.
    Terry FE; Moise L; Martin RF; Torres M; Pilotte N; Williams SA; De Groot AS
    Expert Rev Vaccines; 2015 Jan; 14(1):21-35. PubMed ID: 25193104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes.
    Rojas-Caraballo J; López-Abán J; Pérez del Villar L; Vizcaíno C; Vicente B; Fernández-Soto P; del Olmo E; Patarroyo MA; Muro A
    PLoS One; 2014; 9(8):e105323. PubMed ID: 25122166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.
    Testa JS; Philip R
    Future Virol; 2012 Nov; 7(11):1077-1088. PubMed ID: 23630544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and approaches for the development of safer immunomodulatory biologics.
    Sathish JG; Sethu S; Bielsky MC; de Haan L; French NS; Govindappa K; Green J; Griffiths CE; Holgate S; Jones D; Kimber I; Moggs J; Naisbitt DJ; Pirmohamed M; Reichmann G; Sims J; Subramanyam M; Todd MD; Van Der Laan JW; Weaver RJ; Park BK
    Nat Rev Drug Discov; 2013 Apr; 12(4):306-24. PubMed ID: 23535934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging vaccine informatics.
    He Y; Rappuoli R; De Groot AS; Chen RT
    J Biomed Biotechnol; 2010; 2010():218590. PubMed ID: 21772787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a branched lipopeptide candidate vaccine against influenza A/Puerto Rico 8/34 which is recognized by human B and T-cell immune responses.
    Samayoa L; Diaz-Mitoma F; Azizi A
    Virol J; 2011 Jun; 8():309. PubMed ID: 21679444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.
    Flower DR; Phadwal K; Macdonald IK; Coveney PV; Davies MN; Wan S
    Immunome Res; 2010 Nov; 6 Suppl 2(Suppl 2):S4. PubMed ID: 21067546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated approach to epitope analysis II: A system for proteomic-scale prediction of immunological characteristics.
    Bremel RD; Homan EJ
    Immunome Res; 2010 Nov; 6():8. PubMed ID: 21044290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium immunomics.
    Doolan DL
    Int J Parasitol; 2011 Jan; 41(1):3-20. PubMed ID: 20816843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.